{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:32:26Z","timestamp":1791063146232,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd002829.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2007,1,24]],"date-time":"2007-01-24T00:00:00Z","timestamp":1169596800000}}],"reference-count":49,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd002829.pub4","type":"journal-article","created":{"date-parts":[[2007,1,25]],"date-time":"2007-01-25T08:35:23Z","timestamp":1169714123000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Antioxidant treatment for amyotrophic lateral sclerosis or motor neuron disease"],"prefix":"10.1002","volume":"2011","author":[{"given":"Richard W","family":"Orrell","sequence":"first","affiliation":[{"name":"University College London Institute of Neurology; Department of Clinical Neurosciences; Royal Free Campus Rowland Hill Street London UK NW2 3PF"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell JM","family":"Lane","sequence":"additional","affiliation":[{"name":"Imperial College NHS Trust; West London Neurosciences Centre; Charing Cross Hospital, Fulham Palace Road London UK W6 8RF"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Ross","sequence":"additional","affiliation":[{"name":"Mayo Clinic Scottsdale; Department of Neurology; 13400 East Shea Boulevard Scottsdale Arizona USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,1,24]]},"reference":[{"issue":"3-4","key":"10.1002\/14651858.CD002829.pub4-BIB0001|cit1","first-page":"325","article-title":"Glutathione peroxidase in amyotrophic lateral sclerosis: the effects of selenium supplementation","volume":"17","author":"Apostolski","year":"1998","journal-title":"Journal of Environmental Pathology, Toxicology and Oncology"},{"issue":"1","key":"10.1002\/14651858.CD002829.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/146608201300079364","article-title":"A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis","volume":"2","author":"Desnuelle","year":"2001","journal-title":"Amyotrophic Lateral Sclerosis and other motor neuron disorders"},{"key":"10.1002\/14651858.CD002829.pub4-BIB0003|cit3","first-page":"A127","article-title":"Combination antioxidant therapy in amyotrophic lateral sclerosis","volume":"48","author":"Ellis","year":"1997","journal-title":"Neurology"},{"issue":"5","key":"10.1002\/14651858.CD002829.pub4-BIB0004|cit4","first-page":"649","article-title":"High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study","volume":"112","author":"Graf","year":"2005","journal-title":"Journal of Neurotransmission"},{"key":"10.1002\/14651858.CD002829.pub4-BIB0005|cit5","first-page":"237","article-title":"Double blind cross over trial with deprenyl in amyotrophic lateral sclerosis","volume":"41 Suppl","author":"Jossan","year":"1994","journal-title":"Journal of Neural Transmission"},{"issue":"1","key":"10.1002\/14651858.CD002829.pub4-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1001\/archneur.55.1.93","article-title":"Selegiline is ineffective in a collaborative double-blind, placebo-controlled trial for treatment of amyotrophic lateral sclerosis","volume":"55","author":"Lange","year":"1998","journal-title":"Archives of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD002829.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1001\/archneur.1995.00540300031009","article-title":"Randomized, double-blind, controlled trial of acetylcysteine in amyotrophic lateral sclerosis","volume":"52","author":"Louwerse","year":"1995","journal-title":"Archives of Neurology"},{"issue":"8878","key":"10.1002\/14651858.CD002829.pub4-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/0140-6736(93)92906-A","article-title":"Cu\/Zn superoxide dismutase free radicals, and motoneuron disease [Letter]","volume":"342","author":"Mitchell","year":"1993","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD002829.pub4-BIB0009|cit9","first-page":"233","article-title":"Serial studies of free radical and antioxidant activity in motor neurone disease and the effect of selegiline [letter]","volume":"4","author":"Mitchell","year":"1995","journal-title":"Neurodegeneration"},{"key":"10.1002\/14651858.CD002829.pub4-BIB0010|cit10","first-page":"297","article-title":"Indices of free radical and antioxidant activity in amyotrophic lateral sclerosis","volume-title":"ALS - from Charcot to the present and into the future","author":"Mitchell","year":"1994"},{"issue":"2","key":"10.1002\/14651858.CD002829.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ana.21743","article-title":"Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III","volume":"66","author":"Kaufmann","year":"2009","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD002829.pub4-BIB0012|cit12","first-page":"223","article-title":"A controlled trial of combination of methionine and antioxidants in ALS patients","volume":"20","author":"Stevic","year":"2001","journal-title":"Jugoslavenska Medicinska Biokemija"},{"key":"10.1002\/14651858.CD002829.pub4-BIB0013|cit13","unstructured":"Stevic Z Nicolic A Blagojevic D Saicic ZS Apolstolski S Spasic M A controlled trial of combination of methionine and antioxidants in amyotrophic lateral sclerosis Proceedings ALS\/MND International Alliance Meeting, Munich, Germany 1998"},{"issue":"1","key":"10.1002\/14651858.CD002829.pub4-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/ana.20316","article-title":"Vitamin E intake and risk of amyotrophic lateral sclerosis","volume":"57","author":"Ascherio","year":"2005","journal-title":"Annals of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD002829.pub4-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF02341783","article-title":"Reduced glutathione in amyotrophic lateral sclerosis: an open, crossover, randomized trial","volume":"19","author":"Chio","year":"1998","journal-title":"Italian Journal of Neurological Science"},{"issue":"2","key":"10.1002\/14651858.CD002829.pub4-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1001\/jama.1969.03160150043011","article-title":"Therapeutic trial in amyotrophic lateral sclerosis","volume":"209","author":"Dorman","year":"1969","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD002829.pub4-BIB0017|cit17","first-page":"199","article-title":"Metabolic studies and therapeutic trials in amyotrophic lateral sclerosis","volume-title":"Motor neuron diseases","author":"Engel","year":"1969"},{"key":"10.1002\/14651858.CD002829.pub4-BIB0018|cit18","first-page":"25","article-title":"A randomised trial of antioxidative therapy in amyotrophic lateral sclerosis","volume":"243 Suppl","author":"Janik","year":"1996","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD002829.pub4-BIB0019|cit19","first-page":"101","article-title":"The effect of selegiline and vitamin E in the treatment of ALS: an open randomized clinical trial [Polish]","volume":"Suppl 1","author":"Kwiecinski","year":"2001","journal-title":"Neurologia i Neurochirurgia Polska"},{"issue":"4","key":"10.1002\/14651858.CD002829.pub4-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF00863772","article-title":"An open-randomized clinical trial of selegiline in amyotrophic lateral sclerosis","volume":"241","author":"Mazzini","year":"1994","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD002829.pub4-BIB0021|cit21","first-page":"183","article-title":"Nutritional supplements in amyotrophic lateral sclerosis","volume":"209","author":"Norris","year":"1987","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"10.1002\/14651858.CD002829.pub4-BIB0022|cit22","first-page":"189","article-title":"Pancreatic dysfunction in amyotrophic lateral sclerosis","volume-title":"Motor neuron diseases","author":"Quick","year":"1969"},{"issue":"XLVIII","key":"10.1002\/14651858.CD002829.pub4-BIB0023|cit23","first-page":"821","article-title":"Assessment of the efficacy of treatment with pimozide in patients with amyotrophic lateral sclerosis","volume":"T32","author":"Szczudilk","year":"1998","journal-title":"Neurologia i Neurochirurgia Polska"},{"key":"10.1002\/14651858.CD002829.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0022-510X(96)00071-8","article-title":"Survival in patients with amyotrophic lateral sclerosis treated with an array of antioxidants","volume":"39 Suppl","author":"Vyth","year":"1996","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1002\/14651858.CD002829.pub4-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/00000441-194012000-00005","article-title":"The treatment of amyotrophic lateral sclerosis with vitamin E (tocopherols)","volume":"200","author":"Wechsler","year":"1940","journal-title":"American Journal of Medical Science"},{"key":"10.1002\/14651858.CD002829.pub4-BIB0026|cit26","first-page":"161","article-title":"The randomized open clinical trial on a novel free radical scavenger edaravone in amyotrophic lateral sclerosis","volume":"7","author":"Zhang","year":"2007","journal-title":"Chinese Journal of Contemporary Neurology and Neurosurgery"},{"issue":"6438","key":"10.1002\/14651858.CD002829.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/364584a0","article-title":"ALS, SOD and peroxynitrite","volume":"364","author":"Beckman","year":"1993","journal-title":"Nature"},{"key":"10.1002\/14651858.CD002829.pub4-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/978-1-4899-0209-2_33","article-title":"Oxidative stress plays a role in the pathogenesis of familial and sporadic amyotrophic lateral sclerosis","volume-title":"Neurodegenerative Diseases","author":"Bergeron","year":"1996"},{"key":"10.1002\/14651858.CD002829.pub4-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0022-510X(94)90191-0","article-title":"El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases\/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial \"Clinical limits of amyotrophic lateral sclerosis\" workshop contributors","volume":"124 Suppl","author":"Brooks","year":"1994","journal-title":"Journal of the Neurological Sciences"},{"issue":"3","key":"10.1002\/14651858.CD002829.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/17482960903358865","article-title":"Toward more efficient clinical trials for amyotrophic lateral sclerosis","volume":"11","author":"Cudkowicz","year":"2010","journal-title":"Amyotrophic Lateral Sclerosis"},{"key":"10.1002\/14651858.CD002829.pub4-BIB0031|cit31","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511663307","volume-title":"Amyotrophic lateral sclerosis: a synthesis of research and clinical practice","author":"Eisen","year":"1998"},{"issue":"1","key":"10.1002\/14651858.CD002829.pub4-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.7326\/0003-4819-142-1-200501040-00112","article-title":"Vitamin E supplements: good in theory, but is the theory good?","volume":"142","author":"Greenberg","year":"2004","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD002829.pub4-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ana.410390203","article-title":"Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis","volume":"39","author":"Gurney","year":"1996","journal-title":"Annals of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD002829.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2165\/00002512-200118090-00004","article-title":"Role of free radicals in the neurodegenerative diseases: Therapeutic implications for antioxidant treatment","volume":"18","author":"Halliwell","year":"2001","journal-title":"Drugs and Aging"},{"key":"10.1002\/14651858.CD002829.pub4-BIB0035|cit35","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008 Available from www.cochrane-handbook.org 2008","DOI":"10.1002\/9780470712184"},{"issue":"1","key":"10.1002\/14651858.CD002829.pub4-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3940(94)90213-5","article-title":"Iron, selenium and glutathione peroxidase activity are elevated in sporadic motor neuron disease","volume":"182","author":"Ince","year":"1994","journal-title":"Neuroscience Letters"},{"key":"10.1002\/14651858.CD002829.pub4-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1600-0404.1989.tb01787.x","article-title":"The pharmacology of selegiline ((-)deprenyl). New aspects","volume":"126","author":"Knoll","year":"1989","journal-title":"Acta Neurologica Scandinavica. Supplementum"},{"issue":"9013","key":"10.1002\/14651858.CD002829.pub4-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0140-6736(96)91680-3","article-title":"A dose-ranging study of riluzole in amyotrophic lateral sclerosis","volume":"347","author":"Lacomblez","year":"1996","journal-title":"Lancet"},{"issue":"8","key":"10.1002\/14651858.CD002829.pub4-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1136\/jnnp.2004.039180","article-title":"Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study","volume":"76","author":"Logroscino","year":"2005","journal-title":"Journal of Neurology Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD002829.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-142-1-200501040-00110","article-title":"Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality","volume":"142","author":"Miller","year":"2004","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD002829.pub4-BIB0041|cit41","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001447.pub2","article-title":"Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND)","author":"Miller","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD002829.pub4-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0733-8619(18)30934-4","article-title":"Heavy metals and trace elements in amyotrophic lateral sclerosis","volume":"5","author":"Mitchell","year":"1987","journal-title":"Neurology Clinics"},{"issue":"1","key":"10.1002\/14651858.CD002829.pub4-BIB0043|cit43","first-page":"70","article-title":"AEOL-10150 (Aeolus)","volume":"7","author":"Orrell","year":"2006","journal-title":"Current Opinion in Investigational Drugs"},{"key":"10.1002\/14651858.CD002829.pub4-BIB0044|cit44","first-page":"5","article-title":"Antioxidant therapy in ALS","volume":"1 Suppl 4","author":"Pioro","year":"2000","journal-title":"ALS and other motor neuron disorders"},{"issue":"6415","key":"10.1002\/14651858.CD002829.pub4-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/362059a0","article-title":"Mutations in CuZn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis","volume":"362","author":"Rosen","year":"1993","journal-title":"Nature"},{"issue":"1","key":"10.1002\/14651858.CD002829.pub4-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/011542659501000119","article-title":"Role of antioxidants in health maintenance","volume":"10","author":"Sardesai","year":"1995","journal-title":"Nutrition in Clinical Practice"},{"issue":"3","key":"10.1002\/14651858.CD002829.pub4-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000086679","article-title":"Amyotrophic lateral sclerosis mortality in the United States, 1979-2001","volume":"25","author":"Sejvar","year":"2005","journal-title":"Neuroepidemiology"},{"key":"10.1002\/14651858.CD002829.pub4-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/jnnp.2005.083378","article-title":"Intake of polyunsaturated fatty acids and vitamin E reduces the risk of developing amyotrophic lateral sclerosis","volume":"78","author":"Veldink","year":"2007","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD002829.pub4-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1527-3458.2006.00009.x","article-title":"Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury","volume":"12","author":"Yoshida","year":"2006","journal-title":"CNS Drug Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD002829.pub4\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:08:22Z","timestamp":1760980102000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD002829.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Neuromuscular Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2007,1,24]]},"references-count":49,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd002829.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,24]]}}}